CONNECTS

Racial disparities in COVID-19 vaccination rates persist as delta variant gains steam

Even as the U.S. approaches a coronavirus vaccination rate of 70 percent, racial disparities in who has gotten vaccinated persist, raising questions about how the communities of color that were hit hardest by the first wave of the pandemic will fare against the rapidly spreading delta variant.

Read More

Rigel Pharmaceuticals (RIGL) Announces ACTIV-4 Host Tissue Study Will Evaluate Fostamatinib In Patents With COVID-19

Rigel Pharmaceuticals (RIGL) today announced that fostamatinib, a novel oral spleen tyrosine kinase (SYK) inhibitor, has been selected for a National Institutes of Health (NIH) trial in hospitalized patients with COVID-19.

Read More

Health disparities and the racial burden of COVID-19

With new evidence suggesting Black and Hispanic populations were disproportionately affected by the pandemic, experts weigh in on the importance of vaccination and addressing health disparities

Read More